Cargando…
Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
De novo malignancies constitute an emerging cause of morbidity after solid organ transplant (SOT), significantly affecting the long-term survival of transplant recipients. Pharmacologic immunosuppression may functionally impair the immunosurveillance in these patients, thereby increasing the risk of...
Autores principales: | Cangemi, Michela, Montico, Barbara, Faè, Damiana A., Steffan, Agostino, Dolcetti, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445870/ https://www.ncbi.nlm.nih.gov/pubmed/30972289 http://dx.doi.org/10.3389/fonc.2019.00160 |
Ejemplares similares
-
Biological Predictors of De Novo Tumors in Solid Organ Transplanted Patients During Oncological Surveillance: Potential Role of Circulating TERT mRNA
por: Cangemi, Michela, et al.
Publicado: (2021) -
Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation
por: Shaw, Reid, et al.
Publicado: (2023) -
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma
por: Mastorci, Katy, et al.
Publicado: (2016) -
Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death
por: Lamberti, María Julia, et al.
Publicado: (2022) -
Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
por: Muraro, Elena, et al.
Publicado: (2022)